Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 8 results
Author
Title
[
Type
]
Year
Filters:
Author
is
Scherl, Ellen J
and
Keyword
is
Crohn Disease
[Clear All Filters]
Journal Article
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Weinstock LB
,
Bosworth BP
,
Scherl EJ
,
Li E
,
Iroku U
,
Munsell MA
,
Mullen GE
,
Walters AS
. 2010.
Crohn's disease is associated with restless legs syndrome.
.
Inflamm Bowel Dis. 16(2):275-9.
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
Craven M
,
Egan CE
,
Dowd SE
,
McDonough SP
,
Dogan B
,
Denkers EY
,
Bowman D
,
Scherl EJ
,
Simpson KW
. 2012.
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease.
.
PLoS One. 7(7):e41594.
Dogan B
,
Suzuki H
,
Herlekar D
,
R Sartor B
,
Campbell BJ
,
Roberts CL
,
Stewart K
,
Scherl EJ
,
Araz Y
,
Bitar PP
et al.
. 2014.
Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
.
Inflamm Bowel Dis. 20(11):1919-32.
Dogan B
,
Fu J
,
Zhang S
,
Scherl EJ
,
Simpson KW
. 2018.
Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
.
J Antibiot (Tokyo). 71(5):485-494.
Kothary V
,
Scherl EJ
,
Bosworth B
,
Jiang Z-D
,
Dupont HL
,
Harel J
,
Simpson KW
,
Dogan B
. 2013.
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
.
Antimicrob Agents Chemother. 57(2):811-7.
Dassopoulos T
,
Cohen RD
,
Scherl EJ
,
Schwartz RM
,
Kosinski L
,
Regueiro MD
. 2015.
Ulcerative Colitis Care Pathway.
.
Gastroenterology. 149(1):238-45.